Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants

BACKGROUND: The immune profile against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has dramatically diversified due to a complex combination of exposure to vaccines and infection by various lineages/variants, likely generating a heterogeneity in protective immunity in a given popula...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyamoto, Sho, Arashiro, Takeshi, Adachi, Yu, Moriyama, Saya, Kinoshita, Hitomi, Kanno, Takayuki, Saito, Shinji, Katano, Harutaka, Iida, Shun, Ainai, Akira, Kotaki, Ryutaro, Yamada, Souichi, Kuroda, Yudai, Yamamoto, Tsukasa, Ishijima, Keita, Park, Eun-Sil, Inoue, Yusuke, Kaku, Yoshihiro, Tobiume, Minoru, Iwata-Yoshikawa, Naoko, Shiwa-Sudo, Nozomi, Tokunaga, Kenzo, Ozono, Seiya, Hemmi, Takuya, Ueno, Akira, Kishida, Noriko, Watanabe, Shinji, Nojima, Kiyoko, Seki, Yohei, Mizukami, Takuo, Hasegawa, Hideki, Ebihara, Hideki, Maeda, Ken, Fukushi, Shuetsu, Takahashi, Yoshimasa, Suzuki, Tadaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Clinical and Translational Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894731/
https://www.ncbi.nlm.nih.gov/pubmed/35261995
http://dx.doi.org/10.1016/j.medj.2022.02.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894731/
https://www.ncbi.nlm.nih.gov/pubmed/35261995
http://dx.doi.org/10.1016/j.medj.2022.02.006

Ejemplares similares